We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants Adcomm to Consider Once-a-Year COVID-19 Vaccinations
FDA Wants Adcomm to Consider Once-a-Year COVID-19 Vaccinations
The FDA wants to annualize COVID-19 vaccination with a bivalent vaccine active against the original Wuhan strain plus two Omicron variants (BA.4 and BA.5).